Jacqueline Randolph is a native of Richmond, Virginia. She graduated from Albright College with a double major in Biology and Chemistry and then received a Masters Degree in Microbiology from Howard University.

Ms. Randolph was employed by Bristol-Myers Squibb Pharmaceutical Company and retired as Associate Director of Operations in Clinical Cancer Research after over thirty-seven years with the company. In that capacity, she directed and managed clinical oncology studies throughout the world traveling to Australia, Canada, Europe, Mexico, and South America as well as to major Cancer Centers in the United States. Her clinical research studies involved comparative and combination modalities of surgery, radiation and chemotherapy. She played a major role in the development and FDA approval of several ethical drugs for the treatment of lung, colorectal and breast cancers.

While working for Bristol-Myers Squibb, she earned an Executive MBA from the University of New Haven and received advanced training in Management from the London School of Business. She also completed a Hospital Residency Program in Medical Oncology at Upstate Medical Center in Syracuse, New York.